Herbas VPB

Print
EN | LT
Supplementary protection
LT - Androgeno receptoriaus moduliatoriaus kristalinės formos
EN - CRYSTALLINE FORMS OF AN ANDROGEN RECEPTOR MODULATOR
SPC
(11) Number of the document C 3533792
(68) Number of the document 3533792
(21) Application number for Supplementary Protection Certificate PA 2021 525
(22) Date of filing the application 2021-11-03
(41) Date of publication of the application 2021-11-25
Date of publication of SPC 2024-07-10
(24) Date of coming into effect of SPC 2033-06-05
Applicant
(71) Sloan Kettering Institute For Cancer Research, 1275 York Avenue, New York, NY 10065, US
Aragon Pharmaceuticals, Inc. , 10990 Wilshire Blvd. Suite 440, Los Angeles, CA 90024, US
Grantee
(73) Sloan Kettering Institute For Cancer Research, 1275 York Avenue, New York, NY 10065, US
Aragon Pharmaceuticals, Inc. , 10990 Wilshire Blvd. Suite 440, Los Angeles, CA 90024, US
Attorney or representative
(74) Aušra PAKĖNIENĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
(93) EU/1/18/1342, 2019-01-14
Calculated date of expiry of the SPC
(94) 2034-01-16
Name of the product protected by the basic patent
(95) Apalutamidas
Legal status
SPC granted
Last update date 2024-07-10